Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease

This publication has 32 references indexed in Scilit:

• Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
  Journal of the American College of Cardiology, 1998
• C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction
  Circulation, 1998
• Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
  New England Journal of Medicine, 1997
• Inflammation, Atherosclerosis, and Ischemic Events — Exploring the Hidden Side of the Moon
  New England Journal of Medicine, 1997
• Production of C-reactive protein and risk of coronary events in stable and unstable angina
  The Lancet, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study
  BMJ, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men
  Archives of internal medicine (1960), 1992
• The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.
  Circulation, 1990